4//SEC Filing
J.H. Whitney Equity Partners VII, LLC 4
Accession 0000950170-25-073478
CIK 0001832332other
Filed
May 15, 8:00 PM ET
Accepted
May 16, 3:41 PM ET
Size
16.0 KB
Accession
0000950170-25-073478
Insider Transaction Report
Form 4
Transactions
- Sale
Common Stock, $0.01 par value
2025-05-14$5.88/sh−29,296$172,260→ 31,231,796 total(indirect: By J.H. Whitney VII, L.P.) - Sale
Common Stock, $0.01 par value
2025-05-14$5.88/sh−14,637$86,066→ 15,603,740 total(indirect: By LLC) - Sale
Common Stock, $0.01 par value
2025-05-14$5.88/sh−1,355$7,967→ 1,444,546 total(indirect: By LLC) - Sale
Common Stock, $0.01 par value
2025-05-15$5.89/sh−30,340$178,703→ 31,201,456 total(indirect: By J.H. Whitney VII, L.P.) - Sale
Common Stock, $0.01 par value
2025-05-15$5.89/sh−15,158$89,281→ 15,588,582 total(indirect: By LLC) - Sale
Common Stock, $0.01 par value
2025-05-15$5.89/sh−1,403$8,264→ 1,443,143 total(indirect: By LLC)
Holdings
- 0
Common Stock, $0.01 par value
Footnotes (4)
- [F1]The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by J.H. Whitney VII, L.P. ("JHW VII"), PSA Healthcare Investment Holding LLC ("PSA Healthcare"), JHW Iliad Holdings LLC, PSA Iliad Holdings LLC ("PSA Iliad Holdings," and, collectively with JHW VII and PSA Healthcare, the "Stockholder Entities") and JHW Iliad Holdings II LLC on December 13, 2024.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.84 to $5.94. The reporting persons hereby undertake to provide, upon request, to the staff of the Securities and Exchange Commission ("SEC"), the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
- [F3]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.84 to $5.96. The reporting persons hereby undertake to provide, upon request, to the staff of the SEC, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4.
- [F4]J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of JHW VII and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare, and PSA Iliad Holdings. As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of the Stockholder Entities, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
Documents
Issuer
Aveanna Healthcare Holdings, Inc.
CIK 0001832332
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001567459
Filing Metadata
- Form type
- 4
- Filed
- May 15, 8:00 PM ET
- Accepted
- May 16, 3:41 PM ET
- Size
- 16.0 KB